ACTICOR BIOTECH: Acticor Biotech Announces FDA Acceptance of

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT), a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, today announces that the U.S Food and Drug

Related Keywords

Mediolanum , Lombardia , Italy , France , French , Newton Biocapital , Gilles Avenard , James Grotta , Venture Investment , International Investors Karista , French National Institute Of Health , Drug Administration , Texas Medical Center , Regulatory News , Acticor Biotech , Memorial Hermann Hospital , Global Coordinating Investigator , Chief Executive Officer , Rankin Scale , Acute Respiratory Distress Syndrome , French National Institute , Medical Research , Galien Medstartup Award , International Investors , Mirae Asset Capital , Primer Capital , Euronext Growth , French Autorit , Acticor , Biotech , Nnounces , Acceptance , Application , Lenzocimab , Cute , Ischemic , Stroke ,